Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Enphase Is a Great Company, But ENPH Stock Is Not a Great Pick

By Larry Ramer, InvestorPlace Contributor

Other solar stocks are more likely to outperform than ENPH stock, whose valuation may scare away many investors. Try one of these instead.

ContextLogic Can Still Rebound, but Don’t Buy WISH Stock Just Yet

By Larry Ramer, InvestorPlace Contributor

ContextLogic continues to undertake very good strategies, and WISH stock may become a buy in the second half of the year.

Upstart’s Outlook Has Brightened with Long-Term Opportunities

By Larry Ramer, InvestorPlace Contributor

An improving macro picture as well as new endeavors should boost Upstart and UPST stock in 2022. The stock is a buy for growth investors.

Some Investors Should Buy Novavax Stock on the Dip

By Larry Ramer, InvestorPlace Contributor

Novavax remains poised to sell its coronavirus vaccine to many countries around the world, giving NVAX stock a strong revenue stream in 2022.

The Market Is Greatly Underestimating C3.ai Stock

By Larry Ramer, InvestorPlace Contributor

C3.ai has important advantages over its competitors and has recruited superb partners, while the valuation of AI stock is reasonable.

Load More